Akten FDA Approval History
Last updated by Judith Stewart, BPharm on March 2, 2021.
FDA Approved: Yes (First approved October 7, 2008)
Brand name: Akten
Generic name: lidocaine hydrochloride
Dosage form: Ophthalmic Gel
Company: Akorn, Inc.
Treatment for: Ocular Anesthesia
Akten (lidocaine hydrochloride) Ophthalmic Gel is a topical, ocular anesthetic formulation for use in ocular procedures that require a topical anesthetic agent.
Development timeline for Akten
| Date | Article |
|---|---|
| Oct 8, 2008 | Approval Akorn, Inc. Announces the FDA Approval of Akten Ophthalmic Gel 3.5% |
| Jun 4, 2008 | Akorn, Inc. Receives NDA Approvable Letter for Akten Ophthalmic Gel 3.5% |
| Jun 29, 2007 | Akorn, Inc. Announces the New Drug Application Filing for Akten |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
